CAPITAL FUND MANAGEMENT S.A.

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1323645 PARIS, I0

Position in AUPH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$703,966

+$502,294 QoQ

Shares Held

41,483

+84.7% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#116

of 279 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. AUPH ranks #35 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	155,904	$46,931,781
2	INCY	Incyte Corp	336,318	$38,125,008
3	VRTX	Vertex Pharmaceuticals Inc / Ma	71,088	$35,311,542
4	EXEL	Exelixis, Inc.	527,235	$28,686,856
5	IONS	Ionis Pharmaceuticals Inc	329,554	$26,130,336
6	MRNA	Moderna, Inc.	277,758	$19,451,392
7	CORT	Corcept Therapeutics Inc	184,231	$16,018,885
8	INSM	INSMED Inc	148,976	$15,883,821

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$703,966	41,483	+84.7%	Shares	Sole	2026-08-13
2024-12-31	$201,672	22,458	-18.5%	Shares	Sole	2025-02-13
2024-09-30	$202,080	27,569	-60.5%	Shares	Sole	2024-11-13
2024-06-30	$398,323	69,759	-11.5%	Shares	Sole	2024-08-13
2024-03-31	$394,958	78,834	+1.5%	Shares	Sole	2024-05-15
2023-12-31	$697,929	77,634	-51.6%	Shares	Sole	2024-02-14
2023-09-30	$1,247,224	160,518	+163.8%	Shares	Sole	2023-11-14
2023-06-30	$588,931	60,840	+148.2%	Shares	Sole	2023-08-14
2023-03-31	$268,618	24,509	-87.1%	Shares	Sole	2023-05-15
2022-09-30	$1,429,582	190,104	+34.1%	Shares	Sole	2022-11-14
2022-06-30	$1,424,527	141,744	-0.4%	Shares	Sole	2022-08-12
2022-03-31	$1,762,293	142,350	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.